Literature DB >> 8541935

Divalproex sodium as a treatment for borderline personality disorder.

J A Wilcox1.   

Abstract

Divalproex sodium was given to a series of individuals with the diagnosis of borderline personality disorder. Objective measures of agitation and anxiety were then used to assess the effect of divalproex sodium on such symptoms. Data were collected on the subjects and the amount of time spent in the agitated state was evaluated. We found that divalproex sodium reduced agitation in our subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541935     DOI: 10.3109/10401239509149022

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  9 in total

Review 1.  Psychopharmacology of personality disorders: review and emerging issues.

Authors:  P S Links; A Boggild; N Sarin
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

Review 2.  Update on pharmacotherapy of borderline personality disorder.

Authors:  Mary C Zanarini
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

3.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Pharmacological interventions for obsessive-compulsive personality disorder.

Authors:  Rajesh Alex; Michael Ferriter; Hannah Jones; Nick Huband; Conor Duggan; Birgit A Völlm; Jutta Stoffers; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010

Review 5.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat Khalifa; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

Review 6.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 7.  Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Authors:  Silvio Bellino; Erika Paradiso; Filippo Bogetto
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.

Authors:  Hasan Belli; Cenk Ural; Mahir Akbudak
Journal:  J Clin Med Res       Date:  2012-09-12

9.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat R Khalifa; Simon Gibbon; Birgit A Völlm; Natalie H-Y Cheung; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.